These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27467532)

  • 1. Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism: Who's Conducting the Orchestra?
    Elder GJ
    Transplantation; 2016 Oct; 100(10):2016-7. PubMed ID: 27467532
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.
    Evenepoel P; Claes K; Viaene L; Bammens B; Meijers B; Naesens M; Sprangers B; Kuypers D
    Transplantation; 2016 Oct; 100(10):2188-93. PubMed ID: 27379556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Grade Persistent Hyperparathyroidism After Pediatric Renal Transplant.
    Gulleroglu K; Baskin E; Moray G; Haberal M
    Exp Clin Transplant; 2016 Jun; 14(3):294-8. PubMed ID: 26581346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
    Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary hyperparathyroidism in human kidney transplant recipients.
    Pletka PG; Strom TB; Hampers CL; Griffiths H; Wilson RE; Bernstein DS; Sherwood LM; Merrill JP
    Nephron; 1976; 17(5):371-81. PubMed ID: 787818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hyperparathyroidism on arterial distensibility in renal transplant recipients.
    Barenbrock M; Hausberg M; Kosch M; Kisters K; Hoeks AP; Rahn KH
    Kidney Int; 1998 Jul; 54(1):210-5. PubMed ID: 9648081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Bammens B; Vanrenterghem Y
    Nephrol Dial Transplant; 2004 May; 19(5):1281-7. PubMed ID: 14993493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased parathyroid Klotho expression is associated with persistent hyperparathyroidism after kidney transplantation.
    Hong YA; Choi DE; Lim SW; Yang CW; Chang YK
    Transplant Proc; 2013 Oct; 45(8):2957-62. PubMed ID: 24157012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S; Ghods FJ
    Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
    Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
    Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
    Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
    Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
    Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP
    Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.
    Serra AL; Wuhrmann C; Wüthrich RP
    Am J Kidney Dis; 2008 Dec; 52(6):1151-7. PubMed ID: 18950915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.
    Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y
    Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural History of Serum Calcium and Parathyroid Hormone Following Renal Transplantation.
    Al-Moasseb Z; Aitken E
    Transplant Proc; 2016 Dec; 48(10):3285-3291. PubMed ID: 27931570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of hyperparathyroidism in renal transplant patients].
    Bellamy J; Benoit G; Hiesse C; Charpentier B
    Prog Urol; 1994; 4(4):509-15. PubMed ID: 7920727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cinacalcet in renal transplant patients with hyperparathyroidism.
    Courbebaisse M; Diet C; Timsit MO; Mamzer MF; Thervet E; Noel LH; Legendre C; Friedlander G; Martinez F; Prié D
    Am J Nephrol; 2012; 35(4):341-8. PubMed ID: 22473131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
    Nakamura M; Tanaka K; Marui Y; Tomikawa S
    Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.
    Serra AL; Savoca R; Huber AR; Hepp U; Delsignore A; Hersberger M; Wüthrich RP
    Nephrol Dial Transplant; 2007 Feb; 22(2):577-83. PubMed ID: 17005527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parathyroid and bone. Secondary hyperparathyroidism after renal transplantation].
    Negi S; Okamoto M; Shigematsu T
    Clin Calcium; 2007 Dec; 17(12):1880-7. PubMed ID: 18057664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.